Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
Identifieur interne : 004596 ( Main/Merge ); précédent : 004595; suivant : 004597Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?
Auteurs : G. L. Defer [France]Source :
- Revue neurologique : (Paris) [ 0035-3787 ] ; 1999.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001525
- to stream PascalFrancis, to step Curation: 001B20
- to stream PascalFrancis, to step Checkpoint: 001282
Links to Exploration step
Pascal:99-0152819Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="fr" level="a">Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?</title>
<author><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Neurologie Déjerine, CHU de la Côte de Nacre</s1>
<s2>14000 Caen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0152819</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0152819 INIST</idno>
<idno type="RBID">Pascal:99-0152819</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001525</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B20</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001282</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001282</idno>
<idno type="wicri:doubleKey">0035-3787:1999:Defer G:controverse:sur:le</idno>
<idno type="wicri:Area/Main/Merge">004596</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="fr" level="a">Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ?</title>
<author><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Service de Neurologie Déjerine, CHU de la Côte de Nacre</s1>
<s2>14000 Caen</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Région Normandie</region>
<region type="old region" nuts="2">Basse-Normandie</region>
<settlement type="city">Caen</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Revue neurologique : (Paris)</title>
<title level="j" type="abbreviated">Rev. neurol. : (Paris)</title>
<idno type="ISSN">0035-3787</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Revue neurologique : (Paris)</title>
<title level="j" type="abbreviated">Rev. neurol. : (Paris)</title>
<idno type="ISSN">0035-3787</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Comparative study</term>
<term>Dopamine agonist</term>
<term>Dopamine receptor</term>
<term>Early phase</term>
<term>Human</term>
<term>Indication</term>
<term>Levodopa</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Phase initiale</term>
<term>Lévodopa</term>
<term>Chimiothérapie</term>
<term>Antiparkinsonien</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
<term>Stimulant dopaminergique</term>
<term>Traitement</term>
<term>Indication</term>
<term>Etude comparative</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Basse-Normandie</li>
<li>Région Normandie</li>
</region>
<settlement><li>Caen</li>
</settlement>
</list>
<tree><country name="France"><region name="Région Normandie"><name sortKey="Defer, G L" sort="Defer, G L" uniqKey="Defer G" first="G. L." last="Defer">G. L. Defer</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004596 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004596 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Merge |type= RBID |clé= Pascal:99-0152819 |texte= Controverse sur le traitement initial de la maladie de parkinson : L-dopa ou agonistes dopaminergiques ? }}
This area was generated with Dilib version V0.6.29. |